右美托咪定对前列腺癌患者术后认知功能及血清神经功能指标的影响

么安亮; 蔡立松; 席文娟; 李乐乐; 吴景华; 常俊齐

doi:10.13201/j.issn.1001-1420.2019.06.007

右美托咪定对前列腺癌患者术后认知功能及血清神经功能指标的影响

- 1. 华北理工大学附属医院泌尿外科(河北唐山, 063000);
- 2. 开滦总医院麻醉科;
- 3. 秦皇岛慈善医院外科
基金项目:
河北省卫计委科技计划项目(编号20170907)

详细信息

通讯作者: 么安亮,E-mail:anliangyao@163.com

中图分类号: R737.25

收稿日期: 2018-09-04

Effects of dexmedetomidine on postoperative cognitive function and serum neurologic indexes in patients with prostate cancer

- 1. Department of Urology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, 063000, China;
- 2. Department of Anesthesia, KaiLuan General Hospital;
- 3. Department of Surgery, Charitable Hospital of Qinhuangdao

More Information

Corresponding author: YAO Anliang, E-mail: anliangyao@163.com

Received Date: 04 September 2018

摘要

摘要: 目的:研究右美托咪定对前列腺癌患者术后认知功能及血清神经功能指标的影响。方法:选取2016年4月~2018年3月我院收治的80例行腹腔镜前列腺癌根治术患者,根据是否应用右美托咪定随机分为右美托咪定组和对照组,每组40例。比较两组患者术前1 d、术后1 d、术后3 d的简易精神状态量表(MMSE)评分及血清神经功能指标情况。结果:两组患者术后1、3 d的MMSE评分均低于术前,右美托咪定组术后1、3 d的MMSE评分显著高于对照组(P＜0.05)。两组患者术后1、3 d的人神经特异性烯醇化酶(NSE)水平较术前显著升高(P＜0.05),人胰岛素样生长因子1(IGF-1)、转化生长因子β1(TGF-β1)较术前显著降低,其中右美托咪定组NSE升高幅度显著小于对照组(P＜0.05),IGF-1、TGF-β1降低幅度显著小于对照组(P＜0.05)。结论:在前列腺癌患者术中应用右美托咪定能有效改善患者认知功能,对患者的脑组织有很好的保护作用。
- 右美托咪定 /
- 前列腺癌 /
- 认知功能 /
- 神经功能
Abstract: Objective: To study the effect of dexmedetomidine on postoperative cognitive function and serum neurologic indexes in patients with prostate cancer. Method: Selected 80 patients who received laparoscopic radical prostatectomy from April 2016 to March 2018, were randomly divided into the dexmedetomidine group and the control group with 40 cases in each group. The MMSE score and serum nerve function index of the two groups on 1 day before surgery, 1 day after surgery and 3 days after surgery were compared. Result: The MMSE score 1 day and 3 days after surgery were lower than those before surgery in both groups, and the MMSE score of the dexmedetomidine group was significantly higher than that of the control group (P＜0.05). One day and 3 days after surgery, the level of NSE in the two groups were significantly higher (P＜0.05), but IGF-1 and TGF-β1 were significantly lower. The increase of NSE in the dexmedetomidine group was significantly lower than that in the control group (P＜0.05), and the decrease of IGF-1 and TGF-β1 were significantly lower than those in the control group (P＜0.05).Conclusion: The application of dexmedetomidine can effectively improve the cognitive function and protect the brain of patients with prostate cancer.
- dexmedetomidine /
- prostate cancer /
- cognitive function /
- nerve function

HTML全文

参考文献(13)

[1]	Hansen M V.Chronobiology, cognitive fuction and depressive symptoms in surgical patients[J].Dan Med J, 2014, 61 (9):B4914-B4914.
[2]	Terrando N, Brzezinski M, Degos V, et al.Perioperative cognitive decline in the aging population[J].Mayo Clin Proc, 2011, 86 (9):885-893.
[3]	唐健宏, 卓巧惠, 张新莲, 等.前列腺癌根治术后患者生存质量评价及影响因素[J].齐鲁护理杂志, 2011, 17 (11):7-8.
[4]	Ding L, Zhang H, Mi W, et al.Effects of dexmedetomidine on recovery period of anesthesia and postoperative cognitive function after robot-assisted paroscopicradical prostatectomy in the elderly people[J].Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2015, 40 (2):129-135.
[5]	李贵琴, 任春晖.卒中后抑郁患病率与NIHSS、BI和MMSE评分关系的研究[J].现代中西医结合杂志, 2014, 23 (30):3339-3341.
[6]	蔡立松, 王蕊, 郭平选, 等.三种不同麻醉方式对中老年患者术后发生认知功能障碍的对比[J].实用医学杂志, 2018, 34 (11):1902-1906.
[7]	Siegel R, Ma J, Zou Z, et al.Cancer statistics 2014[J].CA Cancer J Clin, 2014, 64 (1):9-29.
[8]	姜帅, 郭剑明, 孙立安, 等.达芬奇机器人手术治疗前列腺癌合并冠心病患者的初步体会[J].临床泌尿外科杂志, 2017, 32 (8):592-594.
[9]	薛蔚.达芬奇机器人辅助腹腔镜前列腺癌根治术治疗局部进展性前列腺癌[J].临床泌尿外科杂志, 2018, 33 (4):253-256.
[10]	Streich B, Decailliot F, Perney C, et al.Increased carbon dioxide absorption during retroperitioneal laparoscopy[J].Br J Anaesth, 2003, 91 (6):793-796.
[11]	王丽萍, 陈国忠.右美托咪啶与异丙酚镇静下允许性高碳酸血症患者颅内压及脑氧代谢的比较[J].中华麻醉学杂志, 2011, 31 (4):397-410.
[12]	方兆晶, 赵倩, 斯妍娜, 等.右美托咪定对腹腔镜前列腺癌根治术老年患者局部脑氧饱和度和术后认知功能的影响[J].临床麻醉学杂志, 2016, 32 (11):1049-1052.
[13]	Rybakowski J K, Bodnar A, Krzywotulski M, et al.Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression[J].J ECT, 2016, 32 (3):164-168.